Mangoceuticals (MGRX) Change in Inventory (2023 - 2024)
Mangoceuticals recorded quarterly Change in Inventory of -$806.0 in Q3 2024, down 86.14% quarter-over-quarter from -$433.0 in Q2 2024, and up 57.87% year-over-year from -$510.56 in Q4 2023.
Mangoceuticals' Change in Inventory history runs 2 years deep, the most recent figure standing at -$806.0 for Q3 2024.
- In Q3 2024, Change in Inventory rose 57.87% year-over-year to -$806.0; the TTM figure through Sep 2024 stood at -$8368.0 (changed N/A YoY), while the FY2023 annual figure was $18501.0, changed N/A from the prior year.
- Change in Inventory came in at -$806.0 for Q3 2024 at Mangoceuticals, down from -$433.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of -$433.0 in Q2 2024 to a low of -$4049.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | -254.83 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -1.47 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -2.70 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | -1.70 Mn |
| 10 | Mangoceuticals | 7.03 Mn | 6.84 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -806.00 |
| Sep 30, 2024 | -806.00 |
| Jun 30, 2024 | -433.00 |
| Jun 30, 2024 | -433.00 |
| Mar 31, 2024 | -4,049.00 |
| Mar 31, 2024 | -4,049.00 |
| Dec 31, 2023 | -3,080.00 |
| Dec 31, 2023 | -3,080.00 |
| Sep 30, 2023 | -1,913.00 |
| Sep 30, 2023 | -1,913.00 |